Skip to content

A research study to evaluate the safety of NNC1679-0001 when given to healthy participants and participants with T2DM

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-523304-68-00
Enrollment
80
Registered
2026-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy participants and participants with type 2 diabetes

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Apr 20, 2026